Moderna Starts Trial of an Omicron-specific COVID-19 Vaccine
Moderna gave its omicron-specific COVID-19 vaccine to the first participant in a clinical trial, the company announced Wednesday. The report comes a few days after Pfizer / BioNTech launched a trial of its shot targeting the fast-spreading variant. From a report: The announcement coincides with the release of data showing Read more…






